The NIPT Trend

A number of companies now offer non-invasive prenatal tests that can, by isolating fetal DNA from the mother's bloodstream, determine if the fetus has a chromosomal disorder. And, as Fortune's Clay Dillow writes, those tests may soon be able to detect even more disorders. "[I]f parents could know more about their child's health before birth, wouldn't they want to?" he adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.